Tonix Pharmaceuticals Holding Corp. — Director's Dealing 2014

Feb 26, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK: 0001430306
Period of Report: 2014-02-11

Reporting Person: MARIO ERNEST (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-11	Stock Option	$15.88	A	5500	Acquired	2024-02-11	Common Stock (5500)	Direct

Footnotes

F1: The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.

F2: The option was granted pursuant to the Issuer's Amended and Restated 2012 Incentive Stock Plan.